Infective endocarditis in patients with hepatic diseases

E. Seminari, A. De Silvestri, V. Ravasio, S. Ludovisi, R. Utili, N. Petrosillo, F. Castelli, M. Bassetti, F. Barbaro, P. Grossi, N. Barzaghi, M. Rizzi, L. Minoli

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Few data have been published regarding the epidemiology and outcome of infective endocarditis (IE) in patients with chronic hepatic disease (CHD). A retrospective analysis of the Studio Endocarditi Italiano (SEI) database was performed to evaluate the epidemiology and outcome of CHD+ patients compared with CHD− patients. The diagnosis of IE was defined in accordance with the modified Duke criteria. Echocardiography, diagnosis, and treatment procedures were in accordance with current clinical practice. Among the 1722 observed episodes of IE, 300 (17.4 %) occurred in CHD+ patients. The cause of CHD mainly consisted of chronic viral infection. Staphylococcus aureus was the most common bacterial species in CHD+ patients; the frequency of other bacterial species (S. epidermidis, streptococci, and enterococci) were comparable among the two groups. The percentage of patients undergoing surgery for IE was 38.9 in CHD+ patients versus 43.7 in CHD− patients (p = 0.06). Complications were more common among CHD+ patients (77 % versus 65.3 %, p <0.001); embolization (43.3 % versus 26.1 %, p <0.001) and congestive heart failure (42 % versus 34.1 %, p = 0.01) were more frequent among CHD+ patients. Mortality was comparable (12.5 % in CHD− and 15 % in CHD+ patients). At multivariable analysis, factors associated with hospital-associated mortality were having an infection sustained by S. aureus, a prosthetic valve, diabetes and a neoplasia, and CHD. Being an intravenous drug user (IVDU) was a protective factor and was associated with a reduced death risk. CHD is a factor worsening the prognosis in patients with IE, in particular in patients for whom cardiac surgery was required.

Original languageEnglish
Pages (from-to)279-284
Number of pages6
JournalEuropean Journal of Clinical Microbiology and Infectious Diseases
Volume35
Issue number2
DOIs
Publication statusPublished - Feb 1 2016

Fingerprint

Endocarditis
Chronic Disease
Liver
Staphylococcus aureus
Epidemiology
Enterococcus
Virus Diseases
Hospital Mortality
Drug Users
Streptococcus
Thoracic Surgery
Echocardiography
Heart Failure

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Infective endocarditis in patients with hepatic diseases. / Seminari, E.; De Silvestri, A.; Ravasio, V.; Ludovisi, S.; Utili, R.; Petrosillo, N.; Castelli, F.; Bassetti, M.; Barbaro, F.; Grossi, P.; Barzaghi, N.; Rizzi, M.; Minoli, L.

In: European Journal of Clinical Microbiology and Infectious Diseases, Vol. 35, No. 2, 01.02.2016, p. 279-284.

Research output: Contribution to journalArticle

Seminari, E, De Silvestri, A, Ravasio, V, Ludovisi, S, Utili, R, Petrosillo, N, Castelli, F, Bassetti, M, Barbaro, F, Grossi, P, Barzaghi, N, Rizzi, M & Minoli, L 2016, 'Infective endocarditis in patients with hepatic diseases', European Journal of Clinical Microbiology and Infectious Diseases, vol. 35, no. 2, pp. 279-284. https://doi.org/10.1007/s10096-015-2541-4
Seminari, E. ; De Silvestri, A. ; Ravasio, V. ; Ludovisi, S. ; Utili, R. ; Petrosillo, N. ; Castelli, F. ; Bassetti, M. ; Barbaro, F. ; Grossi, P. ; Barzaghi, N. ; Rizzi, M. ; Minoli, L. / Infective endocarditis in patients with hepatic diseases. In: European Journal of Clinical Microbiology and Infectious Diseases. 2016 ; Vol. 35, No. 2. pp. 279-284.
@article{2fe612872e124e819f0eef8bb62a7855,
title = "Infective endocarditis in patients with hepatic diseases",
abstract = "Few data have been published regarding the epidemiology and outcome of infective endocarditis (IE) in patients with chronic hepatic disease (CHD). A retrospective analysis of the Studio Endocarditi Italiano (SEI) database was performed to evaluate the epidemiology and outcome of CHD+ patients compared with CHD− patients. The diagnosis of IE was defined in accordance with the modified Duke criteria. Echocardiography, diagnosis, and treatment procedures were in accordance with current clinical practice. Among the 1722 observed episodes of IE, 300 (17.4 {\%}) occurred in CHD+ patients. The cause of CHD mainly consisted of chronic viral infection. Staphylococcus aureus was the most common bacterial species in CHD+ patients; the frequency of other bacterial species (S. epidermidis, streptococci, and enterococci) were comparable among the two groups. The percentage of patients undergoing surgery for IE was 38.9 in CHD+ patients versus 43.7 in CHD− patients (p = 0.06). Complications were more common among CHD+ patients (77 {\%} versus 65.3 {\%}, p <0.001); embolization (43.3 {\%} versus 26.1 {\%}, p <0.001) and congestive heart failure (42 {\%} versus 34.1 {\%}, p = 0.01) were more frequent among CHD+ patients. Mortality was comparable (12.5 {\%} in CHD− and 15 {\%} in CHD+ patients). At multivariable analysis, factors associated with hospital-associated mortality were having an infection sustained by S. aureus, a prosthetic valve, diabetes and a neoplasia, and CHD. Being an intravenous drug user (IVDU) was a protective factor and was associated with a reduced death risk. CHD is a factor worsening the prognosis in patients with IE, in particular in patients for whom cardiac surgery was required.",
author = "E. Seminari and {De Silvestri}, A. and V. Ravasio and S. Ludovisi and R. Utili and N. Petrosillo and F. Castelli and M. Bassetti and F. Barbaro and P. Grossi and N. Barzaghi and M. Rizzi and L. Minoli",
year = "2016",
month = "2",
day = "1",
doi = "10.1007/s10096-015-2541-4",
language = "English",
volume = "35",
pages = "279--284",
journal = "European Journal of Clinical Microbiology and Infectious Diseases",
issn = "0934-9723",
publisher = "Vieweg",
number = "2",

}

TY - JOUR

T1 - Infective endocarditis in patients with hepatic diseases

AU - Seminari, E.

AU - De Silvestri, A.

AU - Ravasio, V.

AU - Ludovisi, S.

AU - Utili, R.

AU - Petrosillo, N.

AU - Castelli, F.

AU - Bassetti, M.

AU - Barbaro, F.

AU - Grossi, P.

AU - Barzaghi, N.

AU - Rizzi, M.

AU - Minoli, L.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Few data have been published regarding the epidemiology and outcome of infective endocarditis (IE) in patients with chronic hepatic disease (CHD). A retrospective analysis of the Studio Endocarditi Italiano (SEI) database was performed to evaluate the epidemiology and outcome of CHD+ patients compared with CHD− patients. The diagnosis of IE was defined in accordance with the modified Duke criteria. Echocardiography, diagnosis, and treatment procedures were in accordance with current clinical practice. Among the 1722 observed episodes of IE, 300 (17.4 %) occurred in CHD+ patients. The cause of CHD mainly consisted of chronic viral infection. Staphylococcus aureus was the most common bacterial species in CHD+ patients; the frequency of other bacterial species (S. epidermidis, streptococci, and enterococci) were comparable among the two groups. The percentage of patients undergoing surgery for IE was 38.9 in CHD+ patients versus 43.7 in CHD− patients (p = 0.06). Complications were more common among CHD+ patients (77 % versus 65.3 %, p <0.001); embolization (43.3 % versus 26.1 %, p <0.001) and congestive heart failure (42 % versus 34.1 %, p = 0.01) were more frequent among CHD+ patients. Mortality was comparable (12.5 % in CHD− and 15 % in CHD+ patients). At multivariable analysis, factors associated with hospital-associated mortality were having an infection sustained by S. aureus, a prosthetic valve, diabetes and a neoplasia, and CHD. Being an intravenous drug user (IVDU) was a protective factor and was associated with a reduced death risk. CHD is a factor worsening the prognosis in patients with IE, in particular in patients for whom cardiac surgery was required.

AB - Few data have been published regarding the epidemiology and outcome of infective endocarditis (IE) in patients with chronic hepatic disease (CHD). A retrospective analysis of the Studio Endocarditi Italiano (SEI) database was performed to evaluate the epidemiology and outcome of CHD+ patients compared with CHD− patients. The diagnosis of IE was defined in accordance with the modified Duke criteria. Echocardiography, diagnosis, and treatment procedures were in accordance with current clinical practice. Among the 1722 observed episodes of IE, 300 (17.4 %) occurred in CHD+ patients. The cause of CHD mainly consisted of chronic viral infection. Staphylococcus aureus was the most common bacterial species in CHD+ patients; the frequency of other bacterial species (S. epidermidis, streptococci, and enterococci) were comparable among the two groups. The percentage of patients undergoing surgery for IE was 38.9 in CHD+ patients versus 43.7 in CHD− patients (p = 0.06). Complications were more common among CHD+ patients (77 % versus 65.3 %, p <0.001); embolization (43.3 % versus 26.1 %, p <0.001) and congestive heart failure (42 % versus 34.1 %, p = 0.01) were more frequent among CHD+ patients. Mortality was comparable (12.5 % in CHD− and 15 % in CHD+ patients). At multivariable analysis, factors associated with hospital-associated mortality were having an infection sustained by S. aureus, a prosthetic valve, diabetes and a neoplasia, and CHD. Being an intravenous drug user (IVDU) was a protective factor and was associated with a reduced death risk. CHD is a factor worsening the prognosis in patients with IE, in particular in patients for whom cardiac surgery was required.

UR - http://www.scopus.com/inward/record.url?scp=84955461416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955461416&partnerID=8YFLogxK

U2 - 10.1007/s10096-015-2541-4

DO - 10.1007/s10096-015-2541-4

M3 - Article

AN - SCOPUS:84955461416

VL - 35

SP - 279

EP - 284

JO - European Journal of Clinical Microbiology and Infectious Diseases

JF - European Journal of Clinical Microbiology and Infectious Diseases

SN - 0934-9723

IS - 2

ER -